EP
SNY icon

Eudaimonia Partners’s Sanofi SNY Stock Holding History

Eudaimonia Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,026
Closed -$301K – 403
2022
Q2 		$301K Buy
6,026
+386
+7% +$20.5K 0.06% 293
2022
Q1 		$290K Buy
+5,640
New +$291K 0.05% 319
2021
Q3 		$244K Hold
5,070
– – 0.04% 336
2021
Q2 		$267K Buy
5,070
+1,782
+54% +$93K 0.05% 322
2021
Q1 		$163K Sell
3,288
-1,782
-35% -$85.6K 0.03% 378
2020
Q4 		$246K Hold
5,070
– – 0.06% 275
2020
Q3 		$254K Hold
5,070
– – 0.07% 251
2020
Q2 		$259K Sell
5,070
-54
-1% -$2.62K 0.1% 209
2020
Q1 		$224K Buy
5,124
+1,782
+53% +$85.3K 0.1% 206
2019
Q4 		$168K Buy
+3,342
New +$157K 0.07% 265

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Eudaimonia Partners's SNY Position: Q3 2022 in Review

Eudaimonia Partners sold out of Sanofi (SNY) in Q3 2022, closing a stake of 6,026 shares — an estimated $301K sold.

Eudaimonia Partners first reported a position in SNY in Q4 2019 and held it in 10 quarters. The position peaked at $301K in Q2 2022. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Eudaimonia Partners reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Eudaimonia Partners sold 6,026 Sanofi shares in Q3 2022, an estimated $301K.
  • Eudaimonia Partners first reported a position in Sanofi in Q4 2019 and held it in 10 quarters.
  • Eudaimonia Partners's Sanofi position peaked at $301K in Q2 2022.
  • 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Eudaimonia Partners's 13F filing for Q3 2022, filed 4 Nov 2022.